drugset / Trial / NCT03879590

Efficacy Of Doxophylline As A Sparing Treatment For Inhaled Corticosteroids In Mexican Children With Asthma

NCT03879590

Phase 3 Unknown 60 enrolled Autonomous University of Nuevo León
RandomizedCrossoverOpen-labelTreatment

Summary

This study evaluated the efficacy of doxophylline as a steroid sparing treatment in Mexican children with asthma treated with medium ir high doses of inhaled corticosteroids (ICS). It is a cross over study in which both groups of patients will receive doxophylline plus a lower steroid dose maintaining the same treatment step according to GINA guidelines, one group will maintain the same treatment dose while the other will start with doxophylline with the lower ICS dose, and by the middle of the study both groups will interchange treatment schemes.

Timeline

Start
2019-05
Primary completion
2019-09
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule
Subject Doxofylline Small molecule 18 mg/kg Oral